Cardiorrespiratory telerabilitation for patients post covid-19 hospitalization in brazil: randomized clinical trial
- Conditions
- Coronavirus infection of unspecified locationCID 10 - B34.2
- Registration Number
- RBR-10c6922p
- Lead Sponsor
- niversidade Federal de São Carlos
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients aged 35 to 85 years; after hospital discharge caused by COVID-19 infection (diagnosis confirmed or highly suspected by laboratory or tomographic examination); hemodynamically stable (absence of severe arrhythmias; uncontrolled arterial hypertension), absence of the use of tracheostomy, and against indication to perform the proposed tests (such as previous orthopedic disease, unstable angina, and acute myocardial infarction in the previous 6 months, severe valve disease, etc); not bedridden, being under medical supervision; who are not being treated for diseases severe chronic conditions (such as cancer, chronic renal failure, neuromuscular diseases) who have access to a cell phone or computer and who have limitations in physical capacity (80% or less in the performance of the proposed physical tests).
Patients with cognitive balance deficit, with the risk of falling when performing the proposed physical tests and giving up participation.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method